Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

BMRN holding history

Biomarin Pharmaceutical Inc in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BMRN overviewAll 13F holders of BMRNFull Q2 2026 holdings

Shares (Q2 2026)
92,214
Value
$5.28M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of BMRN by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202692,214$5.28M<0.1%−190,246−67.4%ReducedHolders
Q1 2026282,460$16.0M<0.1%−721,569−71.9%ReducedHolders
Q4 20251,004,029$59.7M<0.1%+728,791+264.8%AddedHolders
Q3 2025275,238$14.9M<0.1%−840,190−75.3%ReducedHolders
Q2 20251,115,428$61.3M0.1%+569,653+104.4%AddedHolders
Q1 2025545,775$38.6M<0.1%+270,323+98.1%AddedHolders
Q4 2024275,452$18.1M<0.1%+112,104+68.6%AddedHolders
Q3 2024163,348$11.5M<0.1%−105,026−39.1%ReducedHolders
Q2 2024268,374$22.1M<0.1%−153,924−36.4%ReducedHolders
Q1 2024422,298$36.9M<0.1%+229,846+119.4%AddedHolders
Q4 2023192,452$18.6M<0.1%−331,687−63.3%ReducedHolders
Q3 2023524,139$46.4M0.1%−385,678−42.4%ReducedHolders
Q2 2023909,817$78.9M0.1%−221,222−19.6%ReducedHolders
Q1 20231,131,039$110.0M0.2%−278,085−19.7%ReducedHolders
Q4 20221,409,124$145.8M0.2%+389,867+38.3%AddedHolders
Q3 20221,019,257$86.4M0.2%−29,260−2.8%ReducedHolders
Q2 20221,048,517$86.9M0.1%+360,411+52.4%AddedHolders
Q1 2022688,106$53.1M0.1%−233,616−25.3%ReducedHolders
Q4 2021921,722$81.4M0.1%+146,110+18.8%AddedHolders
Q3 2021775,612$59.9M0.1%+254,731+48.9%AddedHolders
Q2 2021520,881$43.5M0.1%−57,605−10.0%ReducedHolders
Q1 2021578,486$43.7M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.